A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
We aimed at highlighting the role of ZNF217, a Krüppel‐like finger protein, in Estrogen Receptor‐α (ERα)‐positive (ER+) and luminal breast cancers. Here we report for the first time that ZNF217 and ERα proteins bind to each other in both breast cancer cells and breast tumour samples, via the ERα hinge domain and the ZNF217 C‐terminal domain. ZNF217 enhances the recruitment of ERα to its estrogen response elements (ERE) and the ERα‐dependent transcription of the GREB1 estrogen‐regulated gene. The prognostic power of ZNF217 mRNA expression levels is most discriminatory in breast cancers classified with a “good prognosis”, particularly the Luminal‐A subclass. A new immunohistochemistry ZNF217 index, based on nuclear and cytoplasmic ZNF217 staining, also allowed the identification of intermediate/poor relapse‐free survivors in the Luminal‐A subgroup. ZNF217 confers tamoxifen resistance in ER+ breast cancer cells and is a predictor of relapse under endocrine therapy in patients with ER+ breast cancer. ZNF217 thus allows the re‐stratification of patients with ER+ breast cancers considered as cancers with good prognosis where no other biomarkers are currently available and widely used. Here we propose a model in ER+ breast cancer where ZNF217‐driven aggressiveness incorporates ZNF217 as a positive enhancer of ERα direct genomic activity and where ZNF217 possesses its highest discriminatory prognostic value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One gene ZNF217 has been functionally related to hormone regulation and involved in estrogen receptor α (ERα)-mediated signal transduction in breast cancer cells and breast tumor samples.23”
From Regulation of RNA splicing in endometrial tissue and its association with endometriosis (2025) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sun, J., Nawaz, Z., & Slingerland, J. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0082 · Cited by 83
Research works printed but not linked: 65
- 10.1038/onc.2009.151 · DOI
- Badia E., 2000, Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling, Cancer Res, 60, 4130
- 10.4161/epi.4.2.7953 · DOI
- 10.1200/JCO.2005.03.3845 · DOI · Paper page
- 10.1200/JCO.2009.26.3756 · DOI · Paper page
- 10.1158/1078-0432.CCR-07-1833 · DOI · Paper page
- 10.1073/pnas.95.15.8703 · DOI · Paper page
- 10.1101/gr.GR1743R · doi:10.1101/gr.gr1743r · Paper page
- 10.1038/sj.onc.1210126 · DOI
- 10.1200/JCO.2010.31.2835 · DOI · Paper page
- 10.1101/gad.1061803 · DOI · Paper page
- 10.1016/j.ejca.2006.11.018 · DOI
- 10.1074/jbc.M114.553511 · DOI
- 10.1210/me.16.5.947 · doi:10.1210/me.16.5.947
- 10.1002/ijc.24750 · DOI
- 10.1007/s10549-012-2148-8 · DOI
- 10.1159/000328054 · DOI · Paper page
- 10.1093/annonc/mdt303 · DOI · Paper page
- 10.1093/annonc/mdr304 · DOI · Paper page
- 10.1093/annonc/mds586 · DOI · Paper page
- 10.1002/ijc.24696 · DOI
- 10.1007/s10549-011-1676-y · DOI
- 10.1007/s10549-008-0242-8 · DOI
- 10.1007/s10549-009-0580-1 · DOI
- 10.1186/1471-2164-7-96 · DOI · Paper page
- 10.1093/hmg/ddi352 · DOI
- 10.1074/jbc.M611752200 · DOI · Paper page
- 10.1038/onc.2010.289 · DOI
- 10.1002/ijc.28741 · DOI
- 10.1016/j.steroids.2010.01.013 · DOI
- 10.1186/1471-2407-6-245 · DOI
- 10.1002/ijc.22300 · DOI
- 10.1158/2159-8290.CD-12-0093 · DOI
- 10.1371/journal.pone.0046410 · DOI
- 10.1186/1471-2164-9-239 · DOI · Paper page
- 10.1210/me.2013-1376 · DOI
- 10.1158/1078-0432.CCR-10-1282 · DOI · Paper page
- Nonet G.H., 2001, The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells, Cancer Res, 61, 1250
- 10.1200/JCO.2008.18.1370 · DOI · Paper page
- 10.1038/35021093 · DOI · Paper page
- 10.1186/bcr1399 · DOI · Paper page
- 10.1093/oxfordjournals.epirev.a036102 · DOI · Paper page
- 10.4149/neo_2010_04_325 · DOI
- 10.1002/emmm.201201615 · DOI
- 10.1128/MCB.00680-06 · DOI · Paper page
- Quinlan K.G., 2007, Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad, Biochim. Biophys. Acta, 1775, 333
- 10.1002/cncr.26598 · DOI
- 10.1210/mend-2-12-1157 · DOI · Paper page
- 10.1210/me.2005-0042 · DOI · Paper page
- 10.1073/pnas.191367098 · DOI · Paper page
- 10.1073/pnas.0932692100 · DOI · Paper page
- 10.1073/pnas.68.7.1542 · DOI · Paper page
- 10.1016/j.molcel.2008.03.022 · DOI · Paper page
- 10.1016/j.mce.2008.07.018 · doi:10.1016/j.mce.2008.07.018
- 10.1128/MCB.00246-08 · DOI
- 10.1186/1476-4598-9-291 · DOI
- 10.1210/me.2007-0242 · DOI
- 10.1677/erc.1.00899 · DOI
- 10.1038/sj.onc.1210269 · DOI
- 10.1677/jme.0.0320397 · DOI
- 10.1186/bcr2158 · doi:10.1186/bcr2158
- 10.1158/0008-5472.CAN-11-3095 · DOI
- 10.1002/ijc.28182 · DOI
- 10.1158/0008-5472.CAN-05-0486 · DOI · Paper page
- 10.1093/nar/gkl764 · DOI
Cited by
Regulation of RNA splicing in endometrial tissue and its association with endometriosis
Yang, F., Qi, T., McRae, A. F., Rogers, P. A. W., Montgomery, G. W., & Mortlock, S. (2025) · iScience · doi:10.1016/j.isci.2025.113207 · Cited by 4
Metadata
- Authors
- Nguyen, N. T., Vendrell, J. A., Poulard, C., Győrffy, B., Goddard-Léon, S., Bièche, I., Corbo, L., Le Romancer, M., Bachelot, T., Treilleux, I., & Cohen, P. A.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2014-06-10
- Volume
- 8
- Issue
- 8
- Pages
- 1441-1457
- ISSN
- 1574-7891
- 1878-0261
- Cited by
- 35
- References
- 1
- Language
- en
- Funders
- PRES/Lyon Science Transfert
- Cancéropôle Lyon Auvergne Rhône-Alpes
- the Department of the Rhône
- Ligue Nationale Contre le Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.